Qiagen, Evotec Form RNAi Imaging Technology Partnership

genomeweb
360dx

Qiagen, Evotec Form RNAi Imaging Technology Partnership

Sep 13, 2004

NEW YORK, Sept. 13 (GenomeWeb News) - Qiagen said today that it has signed a deal to combine its TOM-amidites chemistry-based RNAi products with Evotec Technologies' imaging Opera platform.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

Genomic Analysis of Present-Day Sardinians Shows Significant Influence From Neolithic Sources
Agendia Partners With GeneCast to Launch Tests in China
Thermo Fisher Licenses CRISPR Patents From Broad Institute, ERS Genomics
Resolution Bioscience Earns NY State Approval for Lung Cancer Liquid Biopsy Test
Lucence Diagnostics Names Myanmar Distribution Partner for Cancer Dx Tests
Type 1 Diabetes, Rheumatoid Arthritis Causal Variants Defined by Fine Mapping, Functional Analyses

The Scan

More to Go Around

Congress approved a bill Friday that would increase the US National Institutes of Health's funding by $2 billion for fiscal year 2019.

Call for Ban

UK's Labour Party calls for a ban on non-invasive prenatal testing for determining sex, BBC News reports.

To Worry or Not?

Sarah Lawrence College's Laura Hercher warns in a New York Times op-ed that more people are going to need help figuring out what their consumer genetic testing results mean.

This Week in PLOS

In PLOS this week: intra-tumor heterogeneity patterns, genomic analysis of Thoroughbred horse origins, and more.

Main menu